A share price of Aveanna Healthcare Holdings Inc [AVAH] is currently trading at $7.43, down -0.54%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AVAH shares have gain 5.54% over the last week, with a monthly amount glided 87.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aveanna Healthcare Holdings Inc [NASDAQ: AVAH] stock has seen the most recent analyst activity on August 19, 2025, when UBS upgraded its rating to a Neutral but kept the price target unchanged to $8 for it. Previously, Barclays upgraded its rating to Overweight on August 19, 2025, and kept the price target unchanged to $9.50. On July 21, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $5.50 on July 02, 2025. JP Morgan downgraded its rating to a Underweight. UBS started tracking with a Sell rating for this stock on November 30, 2023, and assigned it a price target of $1.50. In a note dated May 12, 2023, Raymond James downgraded an Mkt Perform rating on this stock.
Aveanna Healthcare Holdings Inc experienced fluctuations in its stock price throughout the past year between $3.67 and $7.69. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Aveanna Healthcare Holdings Inc [NASDAQ: AVAH] shares were valued at $7.43 at the most recent close of the market. An investor can expect a potential return of 21.13% based on the average AVAH price forecast.
Analyzing the AVAH fundamentals
Trailing Twelve Months sales for Aveanna Healthcare Holdings Inc [NASDAQ:AVAH] were 2.18B which represents 16.75% growth. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is -0.19 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-124.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.28 points at the first support level, and at 7.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.71, and for the 2nd resistance point, it is at 7.98.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aveanna Healthcare Holdings Inc [NASDAQ:AVAH] is 1.09. As well, the Quick Ratio is 1.09, while the Cash Ratio is 0.24. Considering the valuation of this stock, the price to sales ratio is 0.71 and price to earnings (TTM) ratio is 98.80.
Transactions by insiders
Recent insider trading involved Cunningham Patrick A., Chief Compliance Officer, that happened on Jun 13 ’25 when 18500.0 shares were sold. 10% Owner, J.H. Whitney Equity Partners V completed a deal on Jun 10 ’25 to sell 0.75 million shares. Meanwhile, 10% Owner VIGANO PAUL R sold 0.75 million shares on Jun 10 ’25.
